Publications, Pharmaceutical

Investigating Storage Options for Pressurized Metered Dose Inhalers

Selecting an appropriate closure system for a pressurized metered dose inhaler is critical for the maintenance of product integrity and safety, over an extended period.

This paper describes a study of the performance of 12 different valve configurations with a fluticasone propionate/salmeterol xinafoate formulation. Via a Design of Experiments study, accelerated testing was carried out by subjecting the samples to extreme stress (50oC/75%RH) over a period of two weeks. A comparison with data generated over a period of 3 months under more benign storage conditions indicates that the shorter testing protocol provides useful, relevant data. It could therefore be used to efficiently inform valve configuration choice in the early stages of product development, to screen more options in a short timeframe and accelerate progress.

Download Publication
8 May 2021

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More

This Might Also Be of Interest

30 Jun 2022

Supporting Patients and HCPs with New Digital Technology

Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
9 Jun 2022

Aptar Pharma discusses digital therapeutics for chronic conditions

Publications, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights

Read More
18 May 2022

Roundtable: Evolution of Pressurized Metered Dose Inhalers to Cut Carbon Emissions

Webinars, Pharmaceutical, Market Insights, Product Solutions, Sustainability, Device Innovations

Read More
16 May 2022

Healthcare Packaging: The Future of Medical Devices

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
1 5 6 7 8 9 19
Back To Top